Schonfeld Strategic Advisors LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1665241 NEW YORK, NY

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,316,346

+$2,421,284 QoQ

Shares Held

370,128

+168.0% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,904,773 across 126 Biotechnology names. VIR ranks #26 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,316,346	370,128	+168.0%	Shares	Sole	2026-05-15
2025-03-31	$895,062	138,127	+164.2%	Shares	Sole	2025-05-15
2024-09-30	$391,547	52,276	-81.0%	Shares	Sole	2024-11-14
2024-06-30	$2,454,272	275,761	+1132.9%	Shares	Sole	2024-08-14
2024-03-31	$226,567	22,366	-86.2%	Shares	Sole	2024-05-15
2023-09-30	$1,519,139	162,128	+582.9%	Shares	Sole	2023-11-14
2023-06-30	$582,366	23,741	-3.5%	Shares	Sole	2023-08-14
2022-12-31	$622,626	24,600	-65.9%	Shares	Sole	2023-02-14
2022-09-30	$1,389,991	72,095	+15.7%	Shares	Sole	2022-11-14
2022-06-30	$1,586,781	62,300	+419.7%	Shares	Sole	2022-08-15
2022-03-31	$308,305	11,987	-43.7%	Shares	Sole	2022-05-16
2021-12-31	$891,831	21,300	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.